Serum ferritin, transferrin and metabolic syndrome are risk factors for subclinical atherosclerosis in Egyptian women with systemic lupus erythematosus (SLE)
Aim of the work: This work aimed to measure serum ferritin and transferrin levels and to study the presence of metabolic syndrome (MetS) in Egyptian systemic lupus erythematosus (SLE) females and to correlate them with disease activity, damage, clinical status and subclinical atherosclerosis. Patien...
Main Authors: | Aliaa El-Hady, Soha Sennara, Yasmin Mosaad, Nisreen Mahmoud |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Egyptian Rheumatologist |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1110116418300681 |
Similar Items
-
Subclinical Atherosclerosis in Systemic Lupus Erythematosus
by: Scalzi, Lisabeth Victoria
Published: (2008) -
The role of interferon regulatory factor-5 in systemic lupus erythematosus (SLE) and SLE-associated atherosclerosis
by: Watkins, Amanda Ann
Published: (2016) -
Serum ferritin level as a marker of disease activity and renal involvement in Egyptian children with juvenile systemic lupus erythematosus
by: Samia Salah-El-Din Mahmoud, et al.
Published: (2018-10-01) -
Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE)
by: Gabriella Moroni, et al.
Published: (2010-01-01) -
Epidemiologi ved systemisk lupus erythematosus (SLE)
by: Inge-Margrethe Gilboe
Published: (2008-01-01)